Boris Johnson slammed for saying ‘greed’ is behind UK vaccine successBoris Johnson’s sense of humour seems to have got him into trouble again, at the most delicate of Share XBoris Johnson slammed for saying ‘greed’ is behind UK vaccine successhttps://pharmaphorum.com/news/boris-johnson-slammed-for-saying-greed-is-behind-uk-vaccine-success/
AZ COVID jab efficacy debate is hindering EU’s vaccine driveThe spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks Share XAZ COVID jab efficacy debate is hindering EU’s vaccine drivehttps://pharmaphorum.com/news/az-covid-jab-efficacy-debate-is-hindering-eus-vaccine-drive/
AstraZeneca to supply nine million more vaccines to EUThe diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to Share XAstraZeneca to supply nine million more vaccines to EUhttps://pharmaphorum.com/news/astrazeneca-to-supply-nine-million-more-vaccines-to-eu/
EU eyes tighter COVID-19 vaccine exports as access gets uglyThe EU has hit back at AstraZeneca’s plan to provide fewer doses of its COVID-19 vaccine than expected, Share XEU eyes tighter COVID-19 vaccine exports as access gets uglyhttps://pharmaphorum.com/news/eu-eyes-tighter-covid-19-vaccine-exports-as-access-gets-ugly/
EU ramps up supply of COVID-19 vaccine, drugsThe European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after Share XEU ramps up supply of COVID-19 vaccine, drugshttps://pharmaphorum.com/news/eu-ramps-up-supply-of-covid-19-vaccine-drugs/
World leaders – minus US, China – back WHO’s COVID-19 driveThe World Health Organization brought together leaders from around the world on Friday in an “unprecedented” alliance to Share XWorld leaders – minus US, China – back WHO’s COVID-19 drivehttps://pharmaphorum.com/news/world-leaders-minus-us-china-back-whos-covid-19-drive/
Division on European HTAThere have been aspirations for closer collaboration between European Union (EU) Member States (MS) on Health Technology Assessment Share XDivision on European HTAhttps://pharmaphorum.com/views-and-analysis/hta-european-health-technology-assessment-division-progress/
Pfizer wins Herceptin biosimilar approval in EuropeEuropean Commission (EC) has approved Pfizer’s Trazimera, for breast and gastric cancer treatment, marking it as pharma’s first Share XPfizer wins Herceptin biosimilar approval in Europehttps://pharmaphorum.com/news/herceptin-biosimilar-european-approval/
Who should pay for HTA?Part of the drive for strengthening EU cooperation on health technology assessment (HTA) is to tackle duplication of Share XWho should pay for HTA?https://pharmaphorum.com/views-analysis-digital/who-should-pay-hta/
